APA (7th ed.) Citation

Zheng, Z., Zhu, H., & Fang, L. Tislelizumab plus chemotherapy versus chemotherapy as first-line treatment for extensive-stage small cell lung cancer: A cost-effectiveness analysis. Public Library of Science (PLoS).

Chicago Style (17th ed.) Citation

Zheng, Zhiwei, Huide Zhu, and Ling Fang. Tislelizumab Plus Chemotherapy Versus Chemotherapy as First-line Treatment for Extensive-stage Small Cell Lung Cancer: A Cost-effectiveness Analysis. Public Library of Science (PLoS).

MLA (9th ed.) Citation

Zheng, Zhiwei, et al. Tislelizumab Plus Chemotherapy Versus Chemotherapy as First-line Treatment for Extensive-stage Small Cell Lung Cancer: A Cost-effectiveness Analysis. Public Library of Science (PLoS).